The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PFS by blinded independent central review (BICR) in the VELIA trial of veliparib (V) plus carboplatin/paclitaxel (CP) and as monotherapy in newly diagnosed patients (pts) with high-grade serous ovarian cancer (HGSC).
 
Carol Aghajanian
Consulting or Advisory Role - Clovis Oncology; Eisai; Immunogen; Mersana; Roche; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Michael A. Bookman
Employment - McKesson
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Clovis Oncology; Endocyte; Immunogen; Mateon Therapeutics; Merck Sharp & Dohme; Pfizer; Tesaro
 
Gini F. Fleming
Honoraria - Curio Science
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); Compugen (Inst); Corcept Therapeutics (Inst); Eisai (Inst); Forty Seven (Inst); Genentech (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); Leap Therapeutics (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Sanofi (Inst); Sermonix Pharmaceuticals (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
(OPTIONAL) Uncompensated Relationships - TTC Oncology
 
Mark F. Brady
Consulting or Advisory Role - Cel-Sci
 
Elizabeth M. Swisher
Stock and Other Ownership Interests - IDEAYA Biosciences
Consulting or Advisory Role - IDEAYA Biosciences
Research Funding - Clovis Oncology; Tesaro
 
Karina Dahl Steffensen
Honoraria - Abbvie; AstraZeneca
Consulting or Advisory Role - Abbvie
Research Funding - AstraZeneca (Inst)
 
Michael Friedlander
Honoraria - AstraZeneca; Lilly; MSD; Novartis; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Lilly; MSD; Novartis; Takeda
Speakers' Bureau - ACT Genomics; AstraZeneca
Research Funding - AstraZeneca (Inst); BeiGene (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Aikou Okamoto
Honoraria - AstraZeneca Japan; Chugai Pharma; MSD
Consulting or Advisory Role - AstraZeneca Japan; Chugai Pharma
Speakers' Bureau - AstraZeneca Japan
Research Funding - Chugai Pharma; Daiichi Sankyo; Fuji Pharma; GenoDive Pharma; Kaken Pharmaceutical; Kissei Pharmaceutical; Kissei Pharmaceutical; Meiji holdings; Mochida Pharmaceutical Co. Ltd.; Novartis; Pfizer; Shinnihonseiyaku; Shionogi; Taiho Pharmaceutical; Tsumura & Co.
 
Kathleen N. Moore
Honoraria - Prime Oncology; Research To Practice
Consulting or Advisory Role - Abbvie; Aravive; AstraZeneca (Inst); Clovis Oncology; Eisai; Genentech/Roche; Immunogen; Janssen Oncology; Merck; Mersana (Inst); OncoMed; Pfizer/EMD Serono; Samumed; TESARO (Inst); Vavotar Life Sciences; VBL Therapeutics
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
 
Danielle Marie Sullivan
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Mathias Fallstrom
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Minh Dinh
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Christine Ratajczak
Employment - Abbvie
Stock and Other Ownership Interests - AbbVie
 
Robert L. Coleman
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche; Genmab; Immunogen; Novocure; Oncolytics; OncoMed; OncoSec; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merck; OncoMed; Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group